KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,096,607 | +31.4% | 63,133 | +6.5% | 0.00% | 0.0% |
| Q2 2023 | $834,408 | +168127.4% | 59,262 | +28.6% | 0.00% | 0.0% |
| Q1 2023 | $496 | -25.4% | 46,091 | +3.8% | 0.00% | 0.0% |
| Q4 2022 | $665 | -99.9% | 44,410 | +3.3% | 0.00% | 0.0% |
| Q3 2022 | $552,000 | +42.3% | 42,983 | +7.3% | 0.00% | 0.0% |
| Q2 2022 | $388,000 | +10.2% | 40,044 | +13.1% | 0.00% | – |
| Q1 2022 | $352,000 | -13.7% | 35,394 | +2.1% | 0.00% | -100.0% |
| Q4 2021 | $408,000 | +1.0% | 34,657 | -2.3% | 0.00% | 0.0% |
| Q3 2021 | $404,000 | -20.5% | 35,469 | -2.7% | 0.00% | 0.0% |
| Q2 2021 | $508,000 | -4.5% | 36,437 | +26.7% | 0.00% | 0.0% |
| Q1 2021 | $532,000 | -0.9% | 28,762 | -5.4% | 0.00% | 0.0% |
| Q4 2020 | $537,000 | +36.3% | 30,417 | +18.3% | 0.00% | 0.0% |
| Q3 2020 | $394,000 | -33.6% | 25,706 | +10.4% | 0.00% | 0.0% |
| Q2 2020 | $593,000 | +126.3% | 23,282 | +37.7% | 0.00% | 0.0% |
| Q1 2020 | $262,000 | +40.1% | 16,907 | +0.3% | 0.00% | – |
| Q4 2019 | $187,000 | +32.6% | 16,863 | +2.0% | 0.00% | – |
| Q3 2019 | $141,000 | -37.1% | 16,528 | -0.2% | 0.00% | – |
| Q2 2019 | $224,000 | -3.0% | 16,566 | +29.3% | 0.00% | – |
| Q1 2019 | $231,000 | +3.6% | 12,811 | +61.2% | 0.00% | – |
| Q4 2018 | $223,000 | – | 7,949 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |